Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma

[1] Siegel RL(2020)Cancer statistics, 2020 Cancer J Clin 70 7-30

[2] Miller KD(2018)WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies World J Urol 36 1913-1926

[3] Jemal A(2018)An Integrated score and Nomogram combining clinical and immunohistochemistry factors to predict high ISUP grade clear cell renal cell carcinoma Front Oncol 8 634-e65

[4] Warren AY(2020)Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer Am J Surg Pathol 44 e47-493

[5] Harrison D(2017)Kidney cancer: activation of oncogenes driven by VHL loss in ccRCC Nat Rev Urol 14 637-385

[6] Wu J(2013)Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC Epigenetics 8 486-27

[7] Xu WH(2018)Loss of nuclear BAP1 expression is associated with high WHO/ISUP grade in clear cell renal cell carcinoma J Pathol Transl Med 52 378-33620

[8] Wei Y(2016)An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC) BMC Genom 17 515-1505

[9] Qu YY(2020)The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy J Cell Physiol 236 1616-204

[10] Zhang HL(2020)Genetic alterations in renal cancers: identification of the mechanisms underlying cancer initiation and progression and of therapeutic targets Medicines 7 44-7330

[1] Siegel RL(2020)Cancer statistics, 2020 Cancer J Clin 70 7-30

[2] Miller KD(2018)WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies World J Urol 36 1913-1926

[3] Jemal A(2018)An Integrated score and Nomogram combining clinical and immunohistochemistry factors to predict high ISUP grade clear cell renal cell carcinoma Front Oncol 8 634-e65

[4] Warren AY(2020)Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer Am J Surg Pathol 44 e47-493

[5] Harrison D(2017)Kidney cancer: activation of oncogenes driven by VHL loss in ccRCC Nat Rev Urol 14 637-385

[6] Wu J(2013)Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC Epigenetics 8 486-27

[7] Xu WH(2018)Loss of nuclear BAP1 expression is associated with high WHO/ISUP grade in clear cell renal cell carcinoma J Pathol Transl Med 52 378-33620

[8] Wei Y(2016)An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC) BMC Genom 17 515-1505

[9] Qu YY(2020)The tumour microenvironment and metabolism in renal cell carcinoma targeted or immune therapy J Cell Physiol 236 1616-204

[10] Zhang HL(2020)Genetic alterations in renal cancers: identification of the mechanisms underlying cancer initiation and progression and of therapeutic targets Medicines 7 44-7330